Signal active
Organization
Contact Information
Overview
Biologics, Inc. is an oncology management services company that empowers healthcare providers, payors and biopharma to optimize cancer care for the best possible outcomes – clinical, financial and emotional. Unifying fragmented healthcare services, Biologics brings efficiency and humanity to oncology care management by focusing on the patient’s best interest as the surest path to managing cost and risk. Biologics is at the center of a rapidly changing oncology environment and supports patients across all treatment modalities. Offering a holistic approach to oncology care, the company provides the following services: Care Integration, Oncology Pharmacy Services, Patient Access Services, Strategic Market Solutions and Clinical Research Services. Biologics was founded in 1994 and maintains headquarters and operations in Cary, North Carolina.
About
Finance, Biotechnology, Health Care, Biopharma, Oncology
1994
251-500
Headquarters locations
Cary, North Carolina, United States, North America
Social
Profile Resume
Biologics headquartered in United States, North America, operates in the Finance, Biotechnology, Health Care, Biopharma, Oncology sector. The company focuses on Finance and has secured $1.2B in funding across 40 round(s). With a team of 251-500 employees, Biologics is actively contributing to advancements in Finance. Their latest funding round, Venture Round - Biologics, raised $821.9K. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
2
0
0
$29.8M
Details
0
Biologics has raised a total of $29.8M in funding over 0 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|
Investors
There is no investor info for this profile.
Recent Activity
News
Aug 28, 2024
SeekingAlpha - Innovent Biologics reports 1H results (OTCMKTS:IVBIY)
News
Mar 07, 2024
Investing.com - China’s Wuxi AppTec, Biologics, tumble as US sanctions threat grows
News
Feb 22, 2024
PRWeb - LabKey Announces Enhanced Support for Antibody Discovery Workflows in Its Biologics LIMS Software
Funding Round
Apr 15, 2015
Biologics raised $29000000 on 2015-04-15 in Venture Round
Funding Round
May 20, 2010
Biologics raised $821889 on 2010-05-20 in Venture Round